NUTMEG: A randomised phase II study of nivolumab and temozolomide (TMZ) versus TMZ alone in elderly patients with newly diagnosed glioblastoma (GBM): Trial in progress

被引：0

作者：

Khasraw, Mustafa ^{[1
,2
]}

McDonald, Kerrie L. ^{[3
]}

Yip, Sonia ^{[4
]}

Verhaak, Roel ^{[5
]}

Heimberger, Amy ^{[6
]}

Hall, Merryn ^{[1
]}

Fisher, Lauren ^{[1
]}

Barnes, Elizabeth ^{[1
]}

Rosenthal, Mark ^{[7
]}

Gedye, Craig ^{[8
]}

Hovey, Elizabeth ^{[9
]}

Ellingson, Benjamin M. ^{[10
]}

Simes, John ^{[1
]}

Tongela, Annette ^{[11
]}

Wheeler, Helen ^{[2
]}

Koh, Eng-Siew ^{[12
]}

Gan, Hui ^{[13
]}

Back, Michael ^{[2
]}

Lwin, Zarnie ^{[14
,15
]}

机构：

[1] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia

[2] Royal North Shore Hosp, St Leonards, NSW, Australia

[3] Univ New South Wales, Kensington, NSW, Australia

[4] Univ Sydney, Sydney Catalyst Translat Canc Res Ctr, Camperdown, NSW, Australia

[5] Jackson Lab Genom Med, Farmington, CT USA

[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[7] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[8] Calvary Mater Newcastle, Waratah, NSW, Australia

[9] Prince Wales Hosp, Randwick, NSW, Australia

[10] Univ Calif Los Angeles, BTIL, Los Angeles, CA USA

[11] Campbelltown Hosp, Campbelltown, NSW, Australia

[12] Liverpool Hosp, Liverpool, NSW, Australia

[13] Austin Hosp, Heidelberg, Vic, Australia

[14] Royal Brisbane Hosp, Brisbane, Qld, Australia

[15] Univ Queensland, Brisbane, Qld, Australia

来源：

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 14卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

415

引用

页码：196 / 197

页数：2

共 50 条

[41] A phase I study of temozolomide (TMZ) and RAD001 in patients (pts) with glioblastoma multiforme (GBM)
Mason, W. P.
MacNeil, M.
Easaw, J.
McIntosh, L.
Lwin, Z.
Chen, E.
Eisenhauer, E. E.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[42] Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy
Jennifer A. Quinn
Sara Xiaoyin Jiang
David A. Reardon
Annick Desjardins
James J. Vredenburgh
Allan H. Friedman
John H. Sampson
Roger E. McLendon
James E. Herndon
Henry S. Friedman
Journal of Neuro-Oncology, 2009, 95 : 393 - 400
[43] Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy
Quinn, Jennifer A.
Jiang, Sara Xiaoyin
Reardon, David A.
Desjardins, Annick
Vredenburgh, James J.
Friedman, Allan H.
Sampson, John H.
McLendon, Roger E.
Herndon, James E., II
Friedman, Henry S.
JOURNAL OF NEURO-ONCOLOGY, 2009, 95 (03) : 393 - 400
[44] Phase III trial of tumor-treating fields (TTFields) together with temozolomide compared with temozolomide (TMZ) alone in patients with newly diagnosed glioblastoma multiforme (NCT00916409).
Kesari, Santosh
Taillibert, Sophie
Kanner, Andrew
Weinberg, Uri
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[45] SURVIVAL AND TOXICITY UPDATE OF THE PHASE 2 TRIAL OF BEVACIZUMAB (BV) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) FOLLOWED BY BV, TMZ, AND IRINOTECAN (CPT-11) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) PATIENTS
Desjardins, Annick
Reardon, David A.
Peters, Katherine B.
Herndon, James E., II
Kirkpatrick, John P.
Friedman, Henry S.
Vredenburgh, James J.
NEURO-ONCOLOGY, 2010, 12 : 77 - 77
[46] RESULTS OF THE OPARATIC TRIAL: A PHASE I DOSE ESCALATION STUDY OF OLAPARIB IN COMBINATION WITH TEMOZOLOMIDE (TMZ) IN PATIENTS WITH RELAPSED GLIOBLASTOMA (GBM)
Chalmers, Anthony
Cruickshank, Garth
Dunn, Laurence
Erridge, Sara
Godfrey, Lisa
Herbert, Christopher
Jefferies, Sarah
Lopez, Juanita
McBain, Catherine
Pittman, Marc
Sleigh, Rebecca
Watts, Colin
Webster-Smith, Mark
Halford, Sarah
NEURO-ONCOLOGY, 2017, 19 : 4 - 4
[47] A randomized phase II trial of veliparib (V), radiotherapy (RT) and temozolomide (TMZ) in patients (pts) with unmethylated MGMT (uMGMT) glioblastoma (GBM).
Khasraw, Mustafa
McDonald, Kerrie Leanne
Rosenthal, Mark
Lwin, Zarnie
Ashley, David M.
Wheeler, Helen
Barnes, Elizabeth
Foote, Matthew C.
Koh, Eng-Siew
Sulman, Erik P.
Back, Michael
Buckland, Michael
Sim, Hao-Wen
Fisher, Lauren
Leonard, Robyn
Hall, Merryn
Yip, Sonia
Simes, John
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[48] PHASE I STUDY OF AZD1775 WITH RADIATION THERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) AND EVALUATION OF INTRATUMORAL DRUG DISTRIBUTION (IDD) IN PATIENTS WITH RECURRENT GBM
Alexander, Brian
Supko, Jeffrey
Agar, Nathalie
Ahluwalia, Manmeet
Desai, Arati
Dietrich, Jorg
Kaley, Thomas
Peereboom, David
Takebe, Naoko
Desideri, Serena
Fisher, Joy
Sims, Megan
Ye, Xiaobu
Ligon, Keith
Nabors, L. Burt
Grossman, Stuart
Wen, Patrick
NEURO-ONCOLOGY, 2018, 20 : 13 - 14
[49] Results of the OPARATIC trial: A phase I dose escalation study of olaparib in combination with temozolomide (TMZ) in patients with relapsed glioblastoma (GBM).
Halford, Sarah E. R.
Cruickshank, Garth
Dunn, Laurence
Erridge, Sara
Godfrey, Lisa
Herbert, Christopher
Jefferies, Sarah
Lopez, Juanita Suzanne
McBain, Catherine
Pittman, Marc
Sleigh, Rebecca
Watts, Colin
Webster-Smith, Mark F.
Chalmers, Anthony J.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[50] A PILOT PHASE II TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIATION THERAPY (hypo-IMRT) COMBINED WITH TEMOZOLOMIDE (TMZ) AND BEVACIZUMAB (BEV) FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)
Ney, Douglas
Carlson, Julie
Damek, Denise
Blatchford, Patrick
Gaspar, Laurie
Kavanagh, Brian
Waziri, Allen
Lillehei, Kevin
Reddy, Krishna
Chen, Changhu
NEURO-ONCOLOGY, 2013, 15 : 80 - 81

← 1 2 3 4 5 →